touchMDT for touchCARDIO

Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia 

The multidisciplinary team

• Primary care physician: Dr Yassir Javaid, UK 

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ASCVD-risk/